Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

05 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/05/3307597/0/en/jade-biosciences-announces-closing-of-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares.html

03 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/03/3306371/0/en/jade-biosciences-announces-proposed-underwritten-public-offering.html

01 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/01/3304176/0/en/jade-biosciences-announces-positive-interim-phase-1-results-for-jade101-demonstrating-potential-best-in-class-profile-and-every-12-week-dosing-in-iga-nephropathy.html

29 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/29/3303809/0/en/jade-biosciences-to-host-conference-call-and-webcast-on-june-1-2026-at-8-00-a-m-et-to-discuss-interim-phase-1-healthy-volunteer-results-for-jade101-a-novel-potentially-best-in-clas.html

26 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/26/3301441/0/en/jade-biosciences-announces-first-participant-dosed-in-first-in-human-phase-1-clinical-trial-of-jade201-a-novel-half-life-extended-afucosylated-anti-baff-receptor-monoclonal-antibod.html

26 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/26/3300937/0/en/jade-biosciences-announces-first-participant-dosed-in-phase-2-juniper-clinical-trial-of-jade101-in-iga-nephropathy.html
ABOUT THIS PAGE